These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 405094)
1. Localization of minor liver-bound metabolites of 3-methyl-p-dimethylaminoazobenzene with anti-hapten antibodies. Carruthers C; Baumler A; Neilson A Cancer Res; 1977 Jul; 37(7 Pt 1):2099-104. PubMed ID: 405094 [No Abstract] [Full Text] [Related]
2. Detection of liver-bound metabolites of azocarcinogens by the use of anti-hapten antibodies. Carruthers C; Baumler A; Neilson A; Pressman D Cancer Res; 1976 May; 36(5):1568-72. PubMed ID: 817798 [TBL] [Abstract][Full Text] [Related]
3. Detection by antihapten antibodies of liver-bound compounds related to azocarcinogens or their metabolites. Carruthers C; Baumler A; Lin JK Oncology; 1979; 36(5):211-5. PubMed ID: 90352 [TBL] [Abstract][Full Text] [Related]
4. A phenylalanine transfer RNA azo dye complex in livers of rats fed diets containing 3'-methyl-4-dimethylaminoazobenzene. Daoud AH; Griffin AC Cancer Res; 1976 Aug; 36(8):2885-90. PubMed ID: 819135 [TBL] [Abstract][Full Text] [Related]
5. Binding of the azocarcinogen 3'-methyl-p-dimethylaminoazobenzene to cellular components of normal rat liver and azocarcinogen-induced hepatomas. Carruthers C; Baumler A; Neilson A; Pressman D Cancer Res; 1975 Dec; 35(12):3798-06. PubMed ID: 172235 [TBL] [Abstract][Full Text] [Related]
6. In vitro incorporation of 3'-methyl-4-dimethylaminoazobenzene into liver nuclei and release of RNA from the nuclei. Patel NT; Yoshida M; Holoubek V Cancer Res; 1981 Mar; 41(3):743-51. PubMed ID: 6780186 [No Abstract] [Full Text] [Related]
7. Binding of 3'-methyl-N,N-dimethyl-4-aminoazobenzene metabolites to rat liver cytosol proteins and ligandin subunits. Ohmi N; Bhargava M; Arias IM Cancer Res; 1981 Sep; 41(9 Pt 1):3461-4. PubMed ID: 6790166 [TBL] [Abstract][Full Text] [Related]
8. Uptake, metabolism, and secretion of 3'-methyl-N,N-dimethyl-4-aminoazobenzene by isolated perfused rat liver. Samuels AR; Theilmann L; Stollman YR; Wolkoff AW; Bhargava MM Drug Metab Dispos; 1987; 15(2):184-8. PubMed ID: 2882975 [TBL] [Abstract][Full Text] [Related]
9. Participation of the microsomal electron transport system in mutagenic activation of 4-dimethylaminoazobenzene, 4-methylaminoazobenzene and their 3'-methyl-derivatives. Igarashi S; Yonekawa H; Kawajiri K; Watanabe J; Kimura T; Kodama M; Nagata C; Tagashira Y Biochem Biophys Res Commun; 1982 May; 106(1):164-9. PubMed ID: 6808998 [No Abstract] [Full Text] [Related]
10. Noncovalent binding of 3'-methyl-N,N-dimethyl-4-aminoazobenzene and its metabolites to liver cytosolic proteins and its role in their nuclear translocation. Srinivasan K; Levine WG; Bhargava MM Drug Metab Dispos; 1987; 15(4):504-10. PubMed ID: 2888624 [TBL] [Abstract][Full Text] [Related]
11. Uptake and hepatobiliary fate of two hepatocarcinogens, N,N-dimethyl-4-aminoazobenzene and 3'-methyl-N,N-dimethyl-4-aminoazobenzene, in the rat. Samuels AR; Bhargava MM; Levine WG Cancer Res; 1983 Oct; 43(10):4816-21. PubMed ID: 6411333 [TBL] [Abstract][Full Text] [Related]
12. Metabolic activation of the hepatocarcinogen 3'-methyl-4-dimethylaminoazobenzene by a rat liver cell-free system. Evidence suggesting the formation of at least two electrophilic metabolites. Labuc GE; Blunck JM Biochem Pharmacol; 1979 Aug; 28(15):2367-73. PubMed ID: 115471 [No Abstract] [Full Text] [Related]
13. Inhibition of chemical carcinogenesis: early increase in tissue uptake and macromolecular binding of [3H]-labelled metabolites of the hepatocarcinogen 3'-methyl-4-dimethylaminoazobenzene in rat liver in vivo in the presence of the tumour inhibitor chloramphenicol. Labuc GE; Blunck JM Biochem Pharmacol; 1980 Aug; 29(16):2252-5. PubMed ID: 6775635 [No Abstract] [Full Text] [Related]
14. Inhibition of 3'-methyl-4-dimethylaminoazobenzene (3'MeDAB)-induced hepatocarcinogenesis in the rat: chloramphenicol inhibits N,N-dimethylaniline N-oxidase and in vitro binding of [3H]3'MeDAB to protein but not to RNA. Labuc GE; Blunck JM Biochem Pharmacol; 1979 Oct; 28(19):3032-4. PubMed ID: 117810 [No Abstract] [Full Text] [Related]
15. Modifications of 3'-methyl-4-dimethylaminoazobenzene carcinogenesis of rat liver and carcinogen metabolism by portacaval anastomosis. Ricco JB; Franco D; Morin J; Decloître F; Bismuth H Cancer Res; 1977 Dec; 37(12):4500-5. PubMed ID: 411569 [TBL] [Abstract][Full Text] [Related]
16. Effect of 3'-methyl-4-dimethylaminoazobenzene on arginine metabolism in rat liver. Gopalakrishna R; Nagarajan B Indian J Biochem Biophys; 1982 Dec; 19(6):411-4. PubMed ID: 6820949 [No Abstract] [Full Text] [Related]
17. Analysis of biliary and urinary metabolites of 3'-methyl-4-(dimethylamino)azobenzene in rats. Mori Y; Hori T; Toyoshi K Gan; 1978 Dec; 69(6):757-62. PubMed ID: 108170 [TBL] [Abstract][Full Text] [Related]
18. Release of repetitive nuclear RNA into the cytoplasm in liver of rats fed 3'-methyl-4-dimethylaminoazobenzene. Patel NT; Folse DS; Holoubek V Cancer Res; 1979 Nov; 39(11):4460-5. PubMed ID: 115575 [No Abstract] [Full Text] [Related]
19. [Distribution of a carcinogen-binding protein in primary liver tumors induced by 3-methyl-4-dimethylaminoazobenzene in rats]. Bannikov GA; Gel'shteĭn VI; Chipysheva TA Biull Eksp Biol Med; 1973 Mar; 75(3):90-2. PubMed ID: 4374978 [No Abstract] [Full Text] [Related]
20. Decreased activation of carcinogens in the liver of carcinogen-resistant rats. Yano M; Higashi T; Kano S; Tateishi N; Kido Y; Mori T; Higashi K; Sakamoto Y Cancer Res; 1989 Oct; 49(19):5352-7. PubMed ID: 2548720 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]